Practical Approaches to Cancer Invasion and Metastases

A Compendium of Radiation Oncologists’ Responses to 40 Histories

  • A. Robert Kagan
  • Richard J. Steckel

Part of the Medical Radiology book series (MEDRAD)

Table of contents

  1. Front Matter
    Pages I-XI
  2. Introduction

    1. A. Robert Kagan, Richard J. Steckel
      Pages 1-3
  3. Prolong Life

    1. Front Matter
      Pages 5-5
    2. Edward C. Halperin
      Pages 7-11
    3. Lester J. Peters, Helmuth Goepfert
      Pages 12-15
    4. J. Frank Wilson, Kevin Murray
      Pages 16-17
    5. James E. Marks
      Pages 22-23
    6. Carl M. Mansfield
      Pages 26-31
  4. Preventive or Anticipatory Irradiation

    1. Front Matter
      Pages 35-35
    2. Alfred L. Goldson
      Pages 37-39
    3. Anas M. El-Mahdi
      Pages 46-48
    4. John Bedwinek
      Pages 49-51
    5. T. J. Brickner Jr
      Pages 55-57
    6. Thomas A. Buchholz, Thomas W. Griffin
      Pages 58-62

About this book

Introduction

In the United States in 1993 the American Cancer Society estimated that there were about 1,300,000 new cases of invasive cancer diagnosed. At the time of presentation about 70% of those patients represented limited local regional disease without evidences of distant dissemination. About 30% of the patients had demonstrated metastatic disease at the time of initial diagnosis or about 390,000 patients. Of those patients with local regional disease about 56% would be cured by the best treatment programs including surgery, radiation therapy with or without chemotherapy when given for cure. Therefore, of the 1,300,000 new cases of invasive cancer, about 509,000 would be cured by the best treatments available. However, about 790,000 patients will have metastatic disease as a part of initial presentation or following the completion of definitive treatment. The majority of the patients with metastatic disease will have metastases to bone as the dominant site of metastatic disease primarily from cancers of the breast and lung but other metastatic sites will be common including lung, liver, mediastinal and retro-peritoneallymph node groups as well as brain and spinal cord. It has been suggested by SMITHERS, CARLING and WINDEYER that the management of the patient with metastatic disease or recurrent disease can be a more difficult problem in management than a patient who is treated for cure.

Keywords

biopsy brain breast cancer cancer computed tomography (CT) imaging lymphoma magnetic resonance imaging (MRI) metastasis metastatic disease oncology radiation radiology radiotherapy tomography

Editors and affiliations

  • A. Robert Kagan
    • 1
  • Richard J. Steckel
    • 2
  1. 1.Department of Radiation OncologySouthern California Permanente Medical GroupLos AngelesUSA
  2. 2.Center for Health Sciences, Johnsson Cancer CenterUniversity of California, Los AngelesLos AngelesUSA

Bibliographic information

  • DOI https://doi.org/10.1007/978-3-642-84885-8
  • Copyright Information Springer-Verlag Berlin Heidelberg 1994
  • Publisher Name Springer, Berlin, Heidelberg
  • eBook Packages Springer Book Archive
  • Print ISBN 978-3-642-84887-2
  • Online ISBN 978-3-642-84885-8
  • Series Print ISSN 0942-5373
  • About this book